Utah Medical Products (UTMD)
Nasdaq Market Open
Utah Medical Products Inc. is a specialty medical device company that designs, manufactures, and markets products used primarily in hospitals, outpatient clinics, and physicians’ offices. The company focuses on proprietary devices, many of which are single-use products intended for critical care, obstetrics, gynecology, neonatal care, urology, blood pressure monitoring, blood collection, and electrosurgery.
Its portfolio includes electrosurgical pencils, tenacula, endoscopic bulb irrigators, blood bag spikes, pressure monitoring accessories, and other devices used in labor and delivery units, intensive care settings, and women’s health procedures. Utah Medical Products is best known for serving niche areas of clinical practice where reliability, sterility, and ease of use are important to caregivers. By concentrating on specialized products rather than broad commodity categories, the company seeks to maintain differentiated offerings for hospitals and healthcare professionals.
The business model combines product development, in-house manufacturing, and distribution to domestic and international customers. As with other medical device makers, Utah Medical Products operates in a regulated environment, with product quality, compliance, and clinical performance central to its reputation. Demand for its devices is tied to hospital procedure volumes, healthcare purchasing trends, and the ongoing need for disposable products that help reduce contamination risk.
For investors, UTMD represents a small-cap medical technology company with a focused product base rather than a diversified healthcare conglomerate. Its appeal rests on specialized manufacturing expertise, established hospital relationships, and exposure to recurring demand for critical care and women’s health devices.
Last updated
- Market Cap
- 212.76M
- P/E
- 19.61
- P/FCF
- 16.34
- P/S
- 5.67
- Enterprise Value
- 125.56M
- Sector
- Health Care
- Industry
- Surgical and Medical Instruments and Apparatus
- Address
- 7043 S 300 WEST, MIDVALE, UT, 84070
Zacks Initiates Coverage of UTMD With Neutral Recommendation
The Zacks Analyst Blog Highlights Apple, Mastercard, Amgen, Utah Medical Products and Bridger Aerospace
Top Stock Reports for Apple, Mastercard & Amgen
Dividend Champion, Contender, And Challenger Highlights: Week Of April 2
Dividend Champion, Contender, And Challenger Highlights: Week Of January 1
Dividend Champion, Contender, And Challenger Highlights: Week Of December 11
Dividend Champion, Contender, And Challenger Highlights: Week Of October 2
Dividend Champion, Contender, And Challenger Highlights: Week Of July 3
Dividend Champion, Contender, And Challenger Highlights: Week Of March 13
Dividend Champions For March 2022
Dividend Champion, Contender, And Challenger Highlights: Week Of February 13
Dividend Champion, Contender, And Challenger Highlights: Week Of October 3
Wall Street ignores these ‘orphan’ stocks, but they’ve beaten the S&P 500 over 20 years
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 212.76M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 125.56M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 19.61
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.77
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 5.67
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 9.15
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3.35
- EPS
- 3.41
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 1.86%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 16.34
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 15.95
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 13.02M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 9.01%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 8.72%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 28.64
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 26.15
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 24.94
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 10.52K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 66.82
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 8.72M | 9.05M | 9.81M | 9.95M | 9.71M |
| Gross profit | 5.28M | 5.26M | 5.6M | 5.6M | 5.54M |
| Operating income | 2.57M | 2.44M | 2.61M | 3.2M | 3.15M |
| EBITDA | 3.24M | 3.19M | 3.37M | 3.94M | 3.86M |
| Net income | 2.6M | 2.57M | 2.63M | 3.05M | 3.04M |
| Basic EPS | 0.82 | 0.8 | 0.82 | 0.94 | 0.92 |
| Diluted EPS | 0.82 | 0.8 | 0.82 | 0.94 | 0.92 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 124.38M | 122.54M | 121.98M | 120.8M | 122.52M |
| Total liabilities | 4.01M | 3.27M | 3.72M | 3.27M | 5.47M |
| Total equity | 120.37M | 119.27M | 118.25M | 117.53M | 117.05M |
| Cash & equivalents | 87.41M | 85.76M | 84.27M | 82.18M | 83.33M |
| Current assets | 100.38M | 97.74M | 96.53M | 94.38M | 96.4M |
| Current liabilities | 3.51M | 2.6M | 3.01M | 2.25M | 4.32M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 3.11M | 3.48M | 3.88M | 2.87M | 4.46M |
| Investing cash flow | -130K | -109K | -27K | -51K | -184K |
| Financing cash flow | -1.12M | -1.97M | -1.64M | -4.49M | -4.24M |
| Change in cash | 1.65M | 1.49M | 2.09M | -1.15M | 349K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SD — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-Q — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| form 3 | Form 3 — Timken Kevin | View Filing | |
| edgar index | 4 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-Q — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Koopman Brian | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 4 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| form 4 | Form 4 — Koopman Brian | View Filing | |
| edgar index | 4 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| form 4 | Form 4 — RICHINS PAUL O | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-Q — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SD — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-Q — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SCHEDULE 13G — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SCHEDULE 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SC 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | SC 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 3 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-Q — UTAH MEDICAL PRODUCTS INC | View Filing | |
| form 3 | Form 3 — Leigh Carrie | View Filing | |
| form 3 | Form 3 — Leigh Carrie | View Filing | |
| edgar index | 4 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SC 13G/A — UTAH MEDICAL PRODUCTS INC | View Filing | |
| form 4 | Form 4 — Koopman Brian | View Filing | |
| edgar index | SC 13G — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 10-Q — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 4 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| form 4 | Form 4 — Koopman Brian | View Filing | |
| edgar index | SD — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 4 — UTAH MEDICAL PRODUCTS INC | View Filing | |
| form 4 | Form 4 — RICHINS PAUL O | View Filing | |
| edgar index | 10-Q — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing | |
| edgar index | 8-K — UTAH MEDICAL PRODUCTS INC | View Filing |